Insights

Strategic Acquisition Ginkgo Bioworks acquired Proofdx in February 2024, representing an immediate sales opportunity to align with a larger parent company’s roadmap in gene editing service offerings and diagnostics integration.

CRISPR-Driven Platform ProofDx is developing a CRISPR-based, point-of-care diagnostic platform for SARS-CoV-2 with ambitions to expand to in-home diagnostics, signaling potential upsell to adjacent at-home health monitoring markets and healthcare facilities seeking rapid, lab-quality results.

Regulatory & Quality Footprint The tech stack includes ISO certifications and ISO 14971 risk management, indicating readiness for regulatory-compliant deployments; this can enable conversations with hospital systems and clinics prioritizing compliant, scalable diagnostics solutions.

Low Revenue, High Growth Current revenue is under one million with substantial funding ($45M), suggesting a lean, scalable platform ready for commercialization upgrades, strategic partnerships, and pilot programs with healthcare networks and distributors.

Strategic Partnerships Recent news of the acquisition by Ginkgo Bioworks creates a pathway for co-selling, integration with broader biotech services, and cross-sell opportunities to its customer base, including gene editing, synthetic biology, and life sciences research clients.

Proof Diagnostics, Inc. Tech Stack

Proof Diagnostics, Inc. uses 8 technology products and services including RT-qPCR, ISO, ISO 13485, and more. Explore Proof Diagnostics, Inc.'s tech stack below.

RT-qPCR

Analytics

ISO

Certificates

ISO 13485

Certificates

Amazon Web Services

Cloud Hosting

Google Hosted Libraries

Content Delivery Network

jQuery

Javascript Libraries

Python

Programming Languages

ISO 14971

Risk And Compliance

Proof Diagnostics, Inc. Email Formats	Example	Percentage
First@proofdx.com	John@proofdx.com	100%

Proof Diagnostics, Inc. Email Formats

Example

Percentage

First@proofdx.com

John@proofdx.com

100%

Frequently Asked Questions

What is Proof Diagnostics, Inc.'s official website and social media links?

Proof Diagnostics, Inc.'s official website is proofdx.com and has social profiles on LinkedIn and Crunchbase.

How much revenue does Proof Diagnostics, Inc. generate?

As of September 2026, Proof Diagnostics, Inc.'s annual revenue is estimated to be <$1M.

What is Proof Diagnostics, Inc.'s NAICS code?

Proof Diagnostics, Inc.'s NAICS code is 3391 - Medical Equipment and Supplies Manufacturing.

How many employees does Proof Diagnostics, Inc. have currently?

As of September 2026, Proof Diagnostics, Inc. has approximately 1 employees across 1 continents, including North America. Key team members include Associate Director, Computational Biology: A. G., Laboratory Operations Manager: A. C. and Laboratory Operations Manager: A. C. Explore Proof Diagnostics, Inc.'s employee directory with LeadIQ.

What industry does Proof Diagnostics, Inc. belong to?

Proof Diagnostics, Inc. operates in the Medical Equipment Manufacturing industry.

What technology does Proof Diagnostics, Inc. use?

Proof Diagnostics, Inc.'s tech stack includes RT-qPCR, ISO, ISO 13485, Amazon Web Services, Google Hosted Libraries, jQuery, Python and ISO 14971.

What is Proof Diagnostics, Inc.'s email format?

Proof Diagnostics, Inc.'s email format typically follows the pattern of First@proofdx.com. Find more Proof Diagnostics, Inc. email formats with LeadIQ.

How much funding has Proof Diagnostics, Inc. raised to date?

As of September 2026, Proof Diagnostics, Inc. has raised $45M in funding. The last funding round occurred on Apr 07, 2022 for $45M.

When was Proof Diagnostics, Inc. founded?

Proof Diagnostics, Inc. was founded in 2020.

Proof Diagnostics, Inc.

Q: What is Proof Diagnostics, Inc.'s official website and social media links?

Proof Diagnostics, Inc.'s official website is proofdx.com. Proof Diagnostics, Inc. has social profiles on LinkedIn.

Q: How many employees does Proof Diagnostics, Inc. have currently?

Proof Diagnostics, Inc. has approximately 1 employees.

Q: What industry does Proof Diagnostics, Inc. belong to?

Proof Diagnostics, Inc. operates in the Medical Equipment Manufacturing industry.

Q: What technology does Proof Diagnostics, Inc. use?

Proof Diagnostics, Inc.'s tech stack includes ISO 14971, ISO 13485, Google Hosted Libraries, Microsoft Excel, ISO.

Q: How much funding has Proof Diagnostics, Inc. raised to date?

Proof Diagnostics, Inc. has raised $45M in funding. The last funding round occurred on Apr 07, 2022 for $45M.

Q: When was Proof Diagnostics, Inc. founded?

Proof Diagnostics, Inc. was founded in 2020.

Q: What is Proof Diagnostics, Inc.'s NAICS code?

Proof Diagnostics, Inc.'s NAICS code is 3391 (Medical Equipment and Supplies Manufacturing).

Medical Equipment ManufacturingMassachusetts, United States0-1 Employees

Proof Diagnostics, Inc. is a medical equipment manufacturing company based in Cambridge, Massachusetts, United States, employing 11-50 people, and operating a website at proofdx.com. It operates as a health technology and diagnostics company developing a CRISPR-based platform for point-of-care testing of SARS-CoV-2, with aims to expand into in-home diagnostics across a broader range of health applications. The company traces its origins to work led by Professor Feng Zhang and colleagues who pivoted their efforts toward addressing the COVID-19 pandemic in early 2020. The platform combines CRISPR and RT-LAMP technologies to enable a simple, streamlined molecular diagnostic test intended for use in clinics, pharmacies, schools, workplaces, and eventually homes. In February 2024, Ginkgo Bioworks acquired Proof Diagnostics, integrating its capabilities into its broader gene editing service offerings.

Insights

Similar companies to Proof Diagnostics, Inc.

Roche

Abbott

Lucira Health

Detect

Visby Medical

Thermo Fisher Scientific

Cue Health